Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Using Mobile Devices for Neurofeedback to Reduce Opioid Use in Chronic Pain

NCT04838925 is registered in ClinicalTrials.gov with CrossComm, Inc. as lead sponsor.

NCT NCT04838925
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04838925 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Using Mobile Devices for Neurofeedback to Reduce Opioid Use in Chronic Pain
Lead sponsor
CrossComm, Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
June 22, 2022
Completion date
April 30, 2024
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic pain, opioid use